X. Bai

Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC)

Jinming Yu, M. Hu, Jia Yang, 2019, Medicine.

PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma

M. Hu, Jia Yang, Xianbin Zhang, 2020, Cancer management and research.

CMAR_A_285691 13233..13239

M. Hu, Jia Yang, Xianbin Zhang, 2020 .

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)

M. Hu, Jin-ming Yu, Jia Yang, 2019, Cancer management and research.

CMAR_A_218842 8893..8903

M. Hu, Jin-ming Yu, Jia Yang, 2019 .

CMAR_A_218842 8893..8903

M. Hu, Jia Yang, Xing-chen Ding, 2019 .

The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy.

M. Hu, Xianbin Zhang, Xing-chen Ding, 2023, International immunopharmacology.